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information was provided to assess the appropriateness of the size of the study sample.
Study design
The study was a randomised controlled trial. All patients were randomised to either the study (mesh repair) or the control group (non-mesh repair). Stratified hospital randomisation was achieved by calling an independent randomisation centre. The study was a multi-centre trial conducted at 6 hospitals. Follow-up was continued for 36 months. The stages of follow-up were 1 week, and 1, 6, 12, 18, 24 and 36 months. Patients who did not visit the outpatient department after 36 months were asked to fill out a questionnaire and were visited at home. The physician was blinded to the method used for inguinal repair.
Thirteen patients (4%) died within the follow-up period and more than 1 month after hernia repair. The causes of death were unrelated to inguinal hernia. A total of 35 patients (12%) were lost to follow-up. Of these, 12 withdrew from follow-up, 12 could not be traced, and 11 patients were followed up in writing at 36 months but were not physically examined at this time. The distribution of those lost to follow-up across the groups was not reported.
Analysis of effectiveness
The basis of the study was intention to treat. The primary health outcome was the number of hernia recurrences. The assessment was carried out through check-ups at the clinic. Other health outcomes analysed included complications such as postoperative wound infection, wound dehiscence, haematoma, seroma, postoperative pain and discomfort.
Quality of life before and after surgery was assessed using the Dutch version of the EuroQol EQ-5D and the EuroQol Visual Analogue Scale. This was administered for self-completion by the patients before the operation and 1 week, 1 month and 6 months after operation. Values for both measures were also obtained from the general population. The valuation tools were not specified.
Operation factors were also reported. These included the median duration of surgery, treatment location, median hospital stay, median time off work, the type of anaesthesia, the type of hernia encountered at operation, and the operator (surgeons or residents assisted by a surgeon). There was no significant difference between the groups for any operation factor.
A univariate statistical analysis was also conducted to identify risk factors associated with recurrence rates.
Effectiveness results
The 3-year cumulative recurrence rates were 7% in the non-mesh repair group and 1% in the mesh repair group. The groups were significantly different, (p=0.009). The one patient who experienced a recurrence from the intervention group had received a resorbable mesh, which was a trial violation. The short-term complications that were considered were postoperative wound infection, wound dehiscence, haematoma and seroma. There was no significant difference between the groups in these respects.
The response rate for quality of life ranged from 49 to 74% in the non-mesh repair group and from 56 to 79% in the mesh repair group, varying at different time periods. The quality of life scores did not differ significantly between the groups at any time. The mean results for either methodology were 85 (standard deviation, SD=8) for the general population and 81 (SD=14) for either study group. difference was found in the quality of life scores between the study groups. Therefore, the authors decided not to use quality of life scores to derive a quality-adjusted life-year measure of benefit. Since adverse effects were considered as well as the number of hernia recurrences, the analysis was considered a cost-consequences analysis and no summary effectiveness measure was used.
Direct costs
Both the hospital and patient costs were included. There was very little breakdown of the unit costs and quantities. The quantities of resources were estimated alongside the clinical trial from September 1993 to January 1999. No price year was reported.
The hospital costs included those for the initial operation, but only the costs of the polypropylene mesh were incorporated. No cost was indicated for the suture (or other) alternative. Other initial operation costs, such as specialists fees, use of operating room (operation duration) and hospital stay were not significantly different between the two strategies. Hence, they were excluded from the analysis. A lump figure was provided for operations for recurrent inguinal hernias. The year(s) of the price and resource data were not stated. The patient costs included visits to the general practitioner, the need for nurse assistance or a housekeeper, and the need for pain medication. A questionnaire about costs was completed at one and 6 months after surgery.
There was no mention of the valuation method, the origin of the prices used, or any adjustment for inflation. It was not stated whether the costs were discounted. Since the follow-up period of the study was 36 months and the costs and benefits could have accrued at any time during this period, both adjustment for inflation and discounting was relevant.
Statistical analysis of costs
The costs were given as point estimates and no statistical analysis was conducted.
Indirect Costs
The duration of sick-leave was considered as an indirect cost, but no other information was given.
Currency
Euros.
Sensitivity analysis
No sensitivity analysis was performed.
Estimated benefits used in the economic analysis
See the 'Effectiveness Results' section.
Cost results
The total intervention and comparator costs were not stated. The incremental cost of using non-mesh repair compared to mesh repair was Euro 6,821. The knock-on costs of operations were dealt with in the costing. Operation-related cost factors and patient costs were not significantly different.
The paper stated two major costs. The cost of polypropylene mesh was Euro 53 and the cost of a repair of a recurrent inguinal hernia was approximately Euro 1,600.
